Biggest News Aggregation in the World
📰 Immune News

Page 31 - Immune News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immune. Real-time updates on events, politics, business and more.

MyJournals.org - Science - 'Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report' (Journal of Medical Case Reports)

MyJournals.org - Science - Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report (Journal of Medical Case Reports)
Medical Case Reports

Molecular Partners to Present Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 ASCO Annual Meeting

MP0317 demonstrates tumor-localized CD40 activation in tumor biopsies through target occupancy and immune cell activation MP0317 demonstrates a favorable safety profile across Q3W and Q1W... | May 25, 2023
United States Noord Holland Institut Claudius Regaud Antonio Ligi Carlos Gomez Roca Seth Lewis

MyJournals.org - Science - 'IJMS, Vol. 24, Pages 9231: COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review' (International Journal of Molecular Sciences)

MyJournals.org - Science - IJMS, Vol. 24, Pages 9231: COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review (International Journal of Molecular Sciences)
Coronavirus Disease Severe Acute Respiratory Syndrome Coronavirus Ovid 19

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Icosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults

–  IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in older adults – –  IVX-A12 was generally well tolerated with no vaccine-related... | May 22, 2023
United States Jessica Yingling Adam Simpson Laurence Watts Niranjan Kanesa Thasan Institute For Protein Design

Alpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congresses

Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present... | May 19, 2023
Soult Ukpyolsi South Korea International Congress On Systemic Lupus Erythematosus European Congress Alpine Immune Sciences Inc Congress Centre

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science